Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · October 11, 2022

Outcomes of Rituximab-Based Treatment in Patients With Primary Cutaneous Follicle Center Lymphoma

Journal of Cutaneous Medicine and Surgery


Additional Info

Journal of Cutaneous Medicine and Surgery
Rituximab Treatment of Primary Cutaneous Follicle Center Lymphoma: A Retrospective Review
J Cutan Med Surg 2022 Sep 22;[EPub Ahead of Print], S Wang, JW Perlmutter, J Johnston, Z Nugent, M Wiseman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading